IR
52
2
AVB
54
2
ED
45
2
MET
64
3
AME
50
-3
LEG
43
3
MAR
59
2
L
41
4
PEP
38
12
MNST
57
-2
KIM
51
-3
DUK
49
2
ADI
57
-3
OKE
48
6
EMR
51
-3
MTB
65
4
EBAY
62
9
MDT
59
2
AVGO
68
-2
AON
49
2
IR
52
2
AVB
54
2
ED
45
2
MET
64
3
AME
50
-3
LEG
43
3
MAR
59
2
L
41
4
PEP
38
12
MNST
57
-2
KIM
51
-3
DUK
49
2
ADI
57
-3
OKE
48
6
EMR
51
-3
MTB
65
4
EBAY
62
9
MDT
59
2
AVGO
68
-2
AON
49
2
Financhill
Back

Arcadis NV 10K Form

Sell
36

ARCAY
Arcadis NV

Last Price:
$50.23
Seasonality Move:
1.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARCAY News And Ratings

See the #1 stock for the next 7 days that we like better than ARCAY

ARCAY Financial Statistics

Sales & Book Value

Annual Sales: $5.4B
Cash Flow: $0
Price / Cash Flow: 38.53
Annual Sales: $14.35
Price / Book: 3.5

Profitability

EPS (TTM): 2.89150
Net Income (TTM): $260.2M
Gross Margin: $4.2B
Return on Equity: 21.28%
Return on Assets: 6.29%

Arcadis NV Earnings Forecast

Key Arcadis NV Financial Ratios

  • The Gross Profit Margin over the past 32 years for ARCAY is 77.68%.
  • The Selling, General & Administrative Expenses for ARCAY have been equal to 1.96% of Gross Profit Margin.
  • The Research & Development expenses have been 1.35% of Revenue.
  • The Interest Expense is 27.16% of Operating Income.
  • The Net Earning history of ARCAY is 4.86% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 19 years.

Arcadis NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Professional Services
Sector: Industrials
Current Symbol: ARCAY
Website: arcadis.com

Debt

Debt-to-Equity Ratio: 0.69
Current Ratio: 1.22
Quick Ratio: 1.17

Price-to-Earnings

Trailing P/E Ratio: 17.19
Forward P/E Ratio: 0

ARCAY Technical Analysis vs Fundamental Analysis

Sell
36
Arcadis NV (ARCAY) is a Sell

Is Arcadis NV a Buy or a Sell?

  • Arcadis NV stock is rated a Sell
    The current Arcadis NV [ARCAY] share price is $50.23. The Score for ARCAY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.